Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

Bullboard (GREY:IPHAF)

View:
Comment by cmcujoon Aug 04, 2010 11:28am

RE: questions

The Company, as at March 31, 2010, had $5.17 million in cash and cash equivalents, accounts receivable of $440,000 and accounts payable and accrued liabilities of $1.47 million. The Company believes ...more  
Post by antoninuson Aug 04, 2010 11:15am

sorry here's the link..u need to scroll down

https://invivoblog.blogspot.com/2009_10_01_archive.html
Post by antoninuson Aug 04, 2010 11:14am

from the IN VIVO blog, 2009- lux and ulrich grau

Lux Biosciences: Like most biotechs, this ophthalmology specialist and its backers might have had their sights set on getting acquired once Phase III data for lead uveitis compound oral voclosporin (a ...more  
Post by antoninuson Aug 04, 2010 10:50am

questions

who does this turn of events benefit, if anyone...?what is lux' cash position? why did ulrich grau leave? was there a conflict of strategy at lux? what is isa's cash position?what is isa's ...more  
Post by singlebogeyon Aug 04, 2010 10:23am

Suprised that there is not more volume

wondering why the volume is not greater? any thoughts? Also how long can this company last without another lifeline? Estimates of how much cash is left and whats the burn rate? anyone?
Post by antoninuson Aug 04, 2010 10:07am

now is the time

now is the time to push forward on finding a partner for TX....this IS the main driver of this company....it NEVER was uveitis...it was ALWAYS transplant. When is this company going to go and find a ...more  
Comment by teeveeon Aug 04, 2010 10:07am

RE: a few questions

Antoninus,I doubt a takeover would happen. If ISA runs out of money, it simply goes bankrupt. Should that happen, and provided that Lux's partnering agreement would survive a bankruptcy, Lux could ...more  
Post by antoninuson Aug 04, 2010 9:57am

a few questions

what is the delay time? what are the outstanding issues that dictate a whole new trial be conducted? It says neither...how dissapointing is this company....and I dont mean lux....I mean, really, how ...more  
Comment by rickkuleszaon Aug 04, 2010 9:56am

RE: Bad News

so foster can extend his job for another year  - 1mm a year with no results guess he is thrilled and doing cartwheels - extention of pay !!!!!HOW DELIGHTFUL ALL THIS IS !!!!!!!
Post by bromley1877on Aug 04, 2010 9:38am

Bad News

The worst of the scenarios. The FDA wants a new trialEDMONTON, Aug. 4 /CNW/ - Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter ...more  
Post by sam00122on Aug 03, 2010 4:59pm

well what do we have here

I am thinking the same as you all that in some way we should have the answer that wwe are looking for but, then agian if you look at this this must take some tiome to go throught.  The fact that ...more  
Comment by BornReady1970on Aug 03, 2010 1:43pm

RE: to be fair

As far as I understand it... the FDA as a public entity must reveal all formal communication with the public at large. What we are awaiting is a formal communication. That said, it's ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities